| 000 | 01730 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516033847.0 | ||
| 264 | 0 | _c20120201 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/j.1365-2133.2011.10387.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStockfleth, E | |
| 245 | 0 | 0 |
_aLow-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cNov 2011 |
||
| 300 |
_a1101-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aDiclofenac _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyaluronic Acid _xtherapeutic use |
| 650 | 0 | 4 |
_aKeratolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKeratosis, Actinic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSalicylic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKerl, H | |
| 700 | 1 | _aZwingers, T | |
| 700 | 1 | _aWillers, C | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 165 _gno. 5 _gp. 1101-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2133.2011.10387.x _zAvailable from publisher's website |
| 999 |
_c20782847 _d20782847 |
||